DIVISLAB's weekly return of 1.68% was in line with its peer CIPLA, but lagged behind DRREDDY's 2.84% return. The stock's volatility of 27.31% was higher than its peers, indicating a riskier investment. Despite a relatively modest return, the stock's Sharpe Ratio of 0.25 suggests that the return was not adequately compensated for the level of risk taken. Overall, DIVISLAB underperformed its peers in terms of risk-adjusted return.

[Volatility: 27.31%]